Non-dilutive funding advances development of differentiated ribosome-targeting antibiotics for serious, drug-resistant infections with high unmet patient need RALEIGH, N.C., July 29, 2025 /PRNewswire/ ...

BEIJING, July 29, 2025 /PRNewswire/ -- Tsingke Biotech, a leading provider of synthetic biology and nucleic acid solutions, successfully hosted the 2025 Small Nucleic Acid Therapeutics Roundtable on ...